Want news about Jubilant Organosys to land in your mailbox?


Buy Jubilant Organosys; target of Rs 203: Reliance Money
Reliance Money has maintained its buy rating on Jubilant Organosys with a revised target price of Rs 203 in ite report dated July 17, 2009.
"Jubilant Organosys reported a muted growth of 8% in its consolidated revenues to Rs 9013 million in Q1FY10, as the Industrial and Performance Products (IPP –that contributes about 30% of total revenue) Revenues saw 8% decline on account of lower realization and product rationalization. Despite global slowdown and inventory issues, Jubilant has been delivering steady growth in its CRAMS operation and we expect similar trend going ahead. Further increasing R&D pacts provide us long term visibility for the company. Also, the margin expansion seems to be continuous process for Jubilant. Looking at the steady revenue growth with better profitability and reducing balance sheet risk for Jubilant, we maintain our 'BUY' rating with the revised target price of Rs 203 (7x FY11EPS), " says Reliance Money's report.
Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
|
|
To read the full report click on the attachment.....
Attachments : Jubilant Organosys Ltd - Q1FY10 Result Update.pdf |
|
What's your Opinion |
Business
Business News | Economy | Earnings | BSE NSE Notices
General News
Current Affairs | Politics | World News | Sports | Entertainment
Corporate Strategy
Management | Advertising | Marketing | Legal
Personal Finance
Tax | Insurance | Credit Cards | Loans | Property | Retirement | Investment Help | Financial Planning | Fixed Income
Markets
Local Market | Global Market | Market Cues | Analysis | Expert & FII outlook | Brokerage Recomendation
Stocks
Stocks in News | Expert Advice | ADRs & GDRs | IPO
Mutual Funds
News | Advice | MF Analysis | Fund Managers Views
Lifestyle
Travel | Wellness | Technology | Auto| Books
Nandan Nilekani
Chairman
UIDAI
How can corporates aid the UID project?
Martin Pieters
MD and CEO
Vodafone
See major growth opportunities in rural India: Vodafone
Rakesh Parikh
VP-Finance
Unichem Lab
Domestic formulations to grow significantly ahead: Unichem
Koshi Varghese
Executive VP-Marketing
MRF
Input costs hitting margins, see tyre price hike ahead: MRF
-
Most Read
-
Most Viewed
- Mkts to react –ve to RBI rate hike move on Monday: Experts
- Will RBI's policy rate hike impact corporates, borrowers?

- Raamdeo Agrawal's top sector picks for your portfolio

- 10-15% mkt rise in a month not good for India: Blackstone

- Persistent IPO clocks highest bid in 26 mths at 93.6 times
- Shree Ganesh Jewellery IPO opens; should you subscribe?
- Expert strategies to trade markets next week

- Persistent Systems: Experts give industry & stock outlook

- Right time to move on, Unilever healthy again: Vindi Banga

- Shankar Sharma's 1-yr trading ban with effect March 19: SAT
- Jewellers head to Dalal Street
Source: Business Line
- Nissan to build plug-in car in UK
Source: ft.com
- Mystery Shopper: Kurtis and cattle in Mumbai
Source: ft.com
- Shree Ganesh plans to raise Rs 375 cr via IPO
Source: Business Line




















